Concert Bio - Articles

NEWS

Articles and insights

Successful strawberry trial in collaboration with vGreens

Trials of five microbial candidates developed by Concert Bio demonstrate improved germination, survival, plant development and leaf area of pre-production strawberry crops.

Dr Stacey Vincent presents to NASA

On June 24th, our Head of Biological R&D, Stacey Vincent, PhD, delivered a talk to scientists at NASA on how Concert Bio is unlocking the potential of the hydroponic microbiome to boost crop yield, resilience, and food safety - even in the most controlled environments.

Dr Paul Rutten presents at CEA 4.0 2025

Our CEO, Dr Paul Rutten, talks to CEA 4.0 about "Developing the First Microbial Biostimulant Tailored to CEA". Paul shared how our team is building next-gen microbial solutions to help greenhouse growers boost yields, reduce inputs, and grow more sustainably, and exploring the science behind Overture™ — our first microbial biostimulant to reach the market.

Concert Bio demonstrates efficacy of microbial candidates in vine crops

We’re thrilled to share that our microbial product candidates have delivered groundbreaking results in an independent tomato trial run by Fyto Ltd. One treatment boosted tomato yield by +15.2% – a major leap in a sector where even +1% is considered a win.

Webinar: The role of microbes in modern soilless cultivation

Missed our webinar? Watch as Jiffy and Concert Bio explore the critical role of the substrate microbiome in modern soilless cultivation. Learn how microbial communities impact plant growth, resilience, and disease resistance in controlled environment agriculture (CEA).

Hortidaily: Concert Bio and Jiffy Growing Solutions collaborate to understand the microbiome in soilless agriculture substrates

In a recent collaboration, Jiffy Group and Concert Bio explored the substrate microbiome's critical role and how understanding it can improve the resilience and productivity of indoor farming.

Forbes: The Top Breakthrough Technologies & Investment Outlook From Leading VCs

Investors are backing companies that combine AI and biotechnology to enhance soil health and crop yields. Companies like Andes.bio, Concert Bio, Exacto, Inevitable Technology, and RhizeBio are developing biological inputs that boost productivity while reducing environmental impact.

Jiffy Growing Solutions and Concert Bio release joint whitepaper on the substrate microbiome in soilless agriculture

This white paper aims to highlight the main materials used in soilless cultivation of plants in indoor agriculture and the importance of the substrate microbiome. While soil science and the complex network of microorganisms in conventional outdoor agriculture has been extensively researched and understood as contributing to plant health and ecosystem resilience, the substrate microbiome in soilless systems is less understood

2024 Trials Performance Report for Overture(TM)

Trials of Concert Bio Overture ™ in commercial systems showed an average increase of 9.9% in lettuce fresh head yield above standard practice.

HortNews: The UK Agri-Tech Centre conducts trials of Concert Bio's first beneficial microbe products

The UK Agri-Tech Centre has worked closely with Concert Bio over the past year to deliver a series of growth trials at our delivery partner site, Stockbridge Technology Centre. They have conducted some high-throughput testing of Concert Bio’s microbial biostimulants within a deep water lettuce production system.

Concert Bio pitch at StartLife Demo Day Fall 2024

Concert Bio helps greenhouse growers improve their yield and prevent disease using microbial products and microbiome monitoring tailored for the unique requirements of hydroponic agriculture.

Concert Bio Secures Funding For Microbiome Optimisation Platform for CEA

With £1.015 million in funding from Innovate UK, Concert Bio’s project aims to transform CEA by optimizing microbiome interventions.

Hortidaily: Why maintaining a sterile growing environment is crucial. Or is it?

Often there is chatter about the level of sterility in a CEA facility, where most growers would swear that they are up to 99% sterile. However, Paul Rutten, an indoor farm microbes specialist, is debunking these 'myths'.

StartLife: Meet the Future of Food

We’re thrilled to unveil the 15 startups selected for the 12th StartLife Accelerate cohort, our biggest ever cohort, marking a significant milestone in our journey towards fostering innovation in the AgriFoodTech sector.

How can microbes help plants grow without soil?

In the latest CC Pod, Jenny explored the journey of Paul Rutten, Founder and CEO of Concert Bio.

Dr Paul Rutten talks to Urban Vine about Concert Bio

This interview details Concert Bio, a company based in the UK. The interview is with Dr. Paul Rutten, Founder & CEO of Concert Bio.

Forbes 30 under 30: Paul Rutten

A platform aiming to transform humanity's relationship with microbial ecosystems, microbiomes, Concert Bio's starting point is soilless agriculture (aka Controlled Environment Agriculture, CEA), which means growing plants without soil, such as in hydroponic greenhouses and vertical farms.

Vertical Farm Daily: How to control the microbiome in soilless cultivation?

Although using microbes in traditional soil agriculture is very well established, the same can’t be said for soilless cultivation. “In this space, there’s an understanding that microbes in the system are crucial, but there’s simply a lack of tools to understand everything that goes on in there."

TechCrunch: Concert Bio lands pre-seed round

Rutten and his colleagues have landed a $1.7 million oversubscribed pre-seed round led by The Venture Collective with strategic investments from Nucleus Capital, Ponderosa Ventures, TET Ventures, Day One Ventures and Possible Ventures. A handful of angels also contributed.

Nordic: Concert Bio in a $1.7 million pre-seed round

Concert Bio in a $1.7 million pre-seed round led by The Venture Collective, joined by Nucleus Capital, Ponderosa, Day One Ventures and Possible Ventures

Concert Bio, Translation and Innovation Hub, 84 Wood Lane, London W12 0BZ, UK
VAT: GB388943724

Privacy Policy

Terms and Conditions